Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 7, pp. 1945-1955
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 20, 2010
- Revision received April 16, 2010
- Accepted May 10, 2010
- Published first June 29, 2010.
Article Versions
- Previous version (June 29, 2010 - 08:59).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- Fabienne Baffert1,
- Catherine H. Régnier1,
- Alain De Pover1,
- Carole Pissot-Soldermann2,
- Gisele A. Tavares3,
- Francesca Blasco4,
- Josef Brueggen1,
- Patrick Chène1,
- Peter Drueckes3,
- Dirk Erdmann1,
- Pascal Furet2,
- Marc Gerspacher2,
- Marc Lang2,
- David Ledieu5,
- Lynda Nolan5,
- Stephan Ruetz1,
- Joerg Trappe3,
- Eric Vangrevelinghe2,
- Markus Wartmann1,
- Lorenza Wyder1,
- Francesco Hofmann1 and
- Thomas Radimerski1
- Authors' Affiliations: 1Disease Area Oncology, 2Global Discovery Chemistry, 3Center for Proteomic Chemistry, 4Metabolism and Pharmacokinetics, and 5Preclinical Safety Clinical Pathology, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Corresponding Authors:
F. Hofmann and T. Radimerski, Disease Area Oncology, Novartis Institutes for BioMedical Research, Klybeckstrasse 141, 4057 Basel, Switzerland. Phone: 41-61-696-2064; Fax: 41-61-696-3835. E-mail: francesco.hofmann{at}novartis.com and thomas.radimerski{at}novartis.com
July 2010
Volume 9, Issue 7
Volume 9, Issue 7
Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
Jump to section
Advertisement